Login to Your Account



Other News To Note


Thursday, June 13, 2013
• Neurovive Pharmaceuticals AB, of Stockholm, Sweden, said it inked a collaboration deal with Isomerase Therapeutics Ltd., of Cambridge, UK, to develop the molecules that were recently acquired from struggling UK firm Biotica Technology Ltd.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription